CureVac NV Company Insiders

CVAC Stock  USD 3.21  0.04  1.26%   
CureVac NV employs about 999 people. The company is managed by 17 executives with a total tenure of roughly 2331 years, averaging almost 137.0 years of service per executive, having 58.76 employees per reported executive. Evaluation of CureVac NV's management performance can provide insight into the firm performance.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.

CureVac NV Management Team Effectiveness

The company has return on total asset (ROA) of (0.2452) % which means that it has lost $0.2452 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.543) %, meaning that it created substantial loss on money invested by shareholders. CureVac NV's management efficiency ratios could be used to measure how well CureVac NV manages its routine affairs as well as how well it operates its assets and liabilities.

CureVac NV Workforce Comparison

CureVac NV is rated second in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 24,726. CureVac NV holds roughly 999 in number of employees claiming about 4% of equities under Health Care industry.

CureVac NV Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. CureVac NV Price Series Summation is a cross summation of CureVac NV price series and its benchmark/peer.

CureVac NV Notable Stakeholders

A CureVac NV stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CureVac NV often face trade-offs trying to please all of them. CureVac NV's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CureVac NV's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About CureVac NV Management Performance

The success or failure of an entity such as CureVac NV often depends on how effective the management is. CureVac NV management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CureVac management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CureVac management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid . The company was founded in 2000 and is headquartered in Tbingen, Germany. Curevac NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 764 people.
Please note, the presentation of CureVac NV's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CureVac NV's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CureVac NV's management manipulating its earnings.

CureVac NV Workforce Analysis

Traditionally, organizations such as CureVac NV use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CureVac NV within its industry.

CureVac NV Manpower Efficiency

Return on CureVac NV Manpower

Revenue Per Employee53.8K
Revenue Per Executive3.2M
Net Loss Per Employee260.4K
Net Loss Per Executive15.3M
Working Capital Per Employee292.3K
Working Capital Per Executive17.2M

Complementary Tools for CureVac Stock analysis

When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Transaction History
View history of all your transactions and understand their impact on performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Valuation
Check real value of public entities based on technical and fundamental data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device